|
|||||
|
|
Cost‐effectiveness of screening for HLA‐B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States |
|
| Authors: | Hyunmi Choi Babak Mohit |
| Abstract: | |
| Keywords: | carbamazepine cost cost‐effectiveness epilepsy genetic screening HLA‐B*1502 Markov model pharmacovigilance public health QALY quality‐adjusted life‐years Stevens‐Johnson syndrome toxic epidermal necrolysis |